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Regulation of plasma leptin in mice: 
influence of age, high-fat diet, and fasting 
BO AHRl?N,l SVEN MANSSON, RONALD L. GINGERICH,3 AND PETER J. HAwL4 
Departments of IMedicine and 2Radiology, Lund University, Malmii, Sweden S-205 02; 
3Linco Research, St. Charles, Missouri 63301; and 4Department of Anatomy, 
Physiology and Cell Biology, School of Veterinary Medicine, and Department of Nutrition, 
University of California, Davis, California 95616 
Ah&n, Bo, Sven Mfmsson, Ronald L. Gingerich, and 
Peter J. Havel. Regulation of plasma leptin in mice: influ- 
ence of age, high-fat diet, and fasting. Am. J. PhysioZ. 273 
(Regulator y Integrative Comp. Physiol. 42): Rll3-R120, 
1997. -Mechanisms regulating circulating leptin are incom- 
pletely understood. We developed a radioimmunoassay for 
mouse leptin to examine the influence of age, dietary fat 
content, and fasting on plasma concentrations of leptin in the 
background strain for the oblob mouse, the C57BL/6J mouse. 
Plasma leptin increased with age [5.3 -+ 0.6 rig/ml at 2 mo 
(n = 23) vs. 14.2 t 1.6 rig/ml at ll& mo (n = 15), P < O.OOl]. 
Across all age groups (2-11 mo, n = 160), log plasma leptin 
correlated with body weight (r = 0.68, P < O.OOOl), plasma 
insulin (r = 0.38, P < O.OOl), and amount of intra-abdominal 
fat (r = 0.90, P < O.OOl), as revealed by magnetic resonance 
imaging. Plasma leptin was increased by a high-fat diet (58% 
fat for 10 mo) and reduced by fasting for 48 h. The reduction of 
plasma leptin was correlated with the reduction of plasma 
insulin (r = 0.43, P = 0.012) but not with the initial body 
weight or the change in body weight. Moreover, the reduction 
in plasma leptin by fasting was impaired by high-fat diet. 
Thus plasma leptin in C57BL/6J mice 1) increases with age or 
a high-fat diet; 2) correlates with body weight, fat content, 
and plasma insulin; and 3) is reduced during fasting by an 
action inhibited by high-fat diet and related to changes of 
plasma insulin. 
ob gene; insulin; C57BL/6J 
LEPTIN, a 16-kDa protein, is the product of the ob gene 
(32). Previous studies in humans and rodents have 
revealed that the expression of the ob gene correlates 
with body fat content (11, 20, 22). After the develop- 
ment of radioimmunoassay for leptin, it has been 
demonstrated that body fat content also correlates with 
circulating plasma leptin levels (7-9,16,18,19,22,23). 
In addition, leptin administration has been shown to 
reduce food intake and increase the energy expenditure 
in mice (4, 12, 26). It has therefore been hypothesized 
that leptin is a humoral signal from adipose tissue that 
acts on the central nervous system to reduce food 
intake in a negative feedback manner (4, 5, 22, 26). 
Thus circulating leptin may be a regulator of body 
adiposity, and therefore factors that influence the nutri- 
tional status might operate through changes of circulat- 
ing leptin. However, the factors involved in the regula- 
tion of circulating leptin concentrations are incompletely 
understood. Therefore, we have developed a radioimmu- 
noassay specific for mouse leptin to examine the changes 
in plasma leptin in C57BL/6J mice, the background 
strain for the oblob mouse, during aging as well as after 
treatment with high-fat diet, which increases body 
weight and induces insulin resistance and ob gene 
expression in this strain (6, 24, 29), and after fasting, 
which reduces body weight and lowers plasma insulin. 
We also characterized the relationship between plasma 
leptin and both intra-abdominal and subcutaneous fat 
content as revealed by magnetic resonance imaging 
(MRI), a sensitive technique for quantifying body fat 
content (1). 
The study in particular examined the relationship 
between plasma leptin and plasma insulin during 
aging and after high-fat diet and fasting, because it has 
previously been demonstrated that increased body fat 
content, as seen in obesity, is accompanied by insulin 
resistance that induces hyperinsulinemia (25) and that 
insulin increases ob gene expression in human, rat, or 
mouse adipocytes (8, 21, 24, 27, 31). Therefore, it is 
possible that insulin contributes to increased ob gene 
expression and the elevated circulating leptin seen in 
obesity. Regulation of ob gene expression by insulin is 
also supported by findings that ob gene expression is 
reduced in streptozotocin-induced diabetes, which is 
accompanied by hypoinsulinemia (3,21,28). Similarly, 
fasting, which reduces circulating insulin, lowers both 
expression of ob gene (3, 8, 11, 21, 28) and circulating 
leptin (2, 11, 22). However, regulation of ob gene 
expression by insulin has been questioned in two 
studies showing that administration of insulin does not 
normalize the lowered ob gene expression seen in 
streptozotocin-induced diabetes (3, 28), although one 
study reported normalization by insulin (2 1). Moreover, 
in humans, short-term administration of moderate 
doses of insulin does not seem to alter plasma leptin (9, 
18, 19), whereas supraphysiological hyperinsulinemia 
(>4 h) does increase plasma leptin in both normal and 
diabetic subjects (14, 30). Therefore, the relationship 
between plasma leptin and physiological changes in 
plasma insulin is not established and needs to be 
further explored. 
MATERIALS AND METHODS 
Animak. Mice of the C57BL/6J strain were obtained from 
Bomholtgaard Breeding and Research Centre, Ry, Denmark, 
at 4 wk of age. Only female mice were used to avoid the 
profound gender differences in circulating leptin that have 
been documented in humans (15). One-half of the mice in 
each batch received a high-fat diet (Research Diets, New 
Brunswick, NJ), and the other one-half of the animals 
received an ordinary rodent chow diet (Lactamin, Stockholm, 
Sweden). On a caloric basis, the high-fat diet consisted of 
16.4% protein, 25.6% carbohydrate, and 58.0% fat (total 23.4 
kJ/g), and the control diet consisted of 25.8% protein, 62.8% 
carbohydrate, and 11.4% fat (total 12.6 kJ/g). Throughout the 
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study period, the mice had free access to food and water. Four 
to five mice were kept per cage in a temperature-controlled 
(22 t l°C) room with a 12:12-h light-dark cycle with light on 
at 0600. The study was approved by the Animal Ethics 
Committee at Lund University. 
Experiments. After 1, 2, 6, and 10 mo of treatment with 
high-fat diet or control diet, i.e., at the age of 2, 3, 7, and 11 
mo, the animals were weighed, and a blood sample taken 
from the intraorbital retrobulbar plexus was placed in hepa- 
rinized, prechilled tubes for the measurement of plasma 
levels of leptin, insulin, and glucose. Furthermore, in the two 
groups, at 3 mo of age, food but not water was withdrawn 
from the cages for 48 h, after which an additional blood 
sample was taken and the animals were weighed. Plasma 
was immediately separated after centrifugation at 4°C and 
stored at -20°C until analysis. 
AnaZyses. A new radioimmunoassay (Linco Research, St. 
Charles, MO) was developed to measure mouse leptin in 
plasma or serum using a polyclonal antibody raised in rabbits 
against highly purified recombinant mouse leptin. Calibra- 
tors (0.2,0.5,1.0,2.0,5.0,1.0, and 20.0 rig/ml) and 1251-labeled 
tracer were prepared with recombinant mouse leptin. Calibra- 
tors (100 ~1) or specimens (25-100 ~1) in duplicate were 
mixed with antibody (100 ~1) and incubated overnight at 4°C. 
If specimen volume was ~100 ~1, the remaining volume was 
adjusted with buffer. 1251-leptin (100 ~1) was added, mixed, 
and incubated an additional 24 h at 4°C. One milliliter of 
precipitating reagent [anti-rabbit rabbit immunoglobin G 
(IgG)] was added to all tubes (except totals) and incubated for 
20 min at 4°C to precipitate the antibody-antigen complex. 
Tubes were centrifuged for 15 min at 2,000 g at 4°C. The 
supernatants were decanted and the pellets were counted to 
determine bound activity. Calculation of unknown concentra- 
tions was accomplished by log/logit transformation. Recovery 
of different amounts of mouse leptin added to a mouse serum 
pool (starting leptin 0.4 rig/ml) is shown in Table 1. Recovery 
ranged from 92 to 100% over a range of 0.4-5.1 rig/ml. Linear 
dilution of four mouse serum specimens (initial concentra- 
tions 2.2, 4.6, 8.1, and 10.5 rig/ml) is shown in Table 2. 
Specimens were measured at 100, 75, and 50 ~1 of serum. 
Recoveries ranged from 100 to 125%. Within- and between- 
assay variations were assessed by repeated analysis of four 
serum samples containing 0.4-5.4 rig/ml leptin. Coefficients 
of variations (CV) ranged from 4.0 to 11.2% within runs and 
from 3.3 to 14.6% between runs (Table 3). Plasma insulin was 
determined radioimmunochemically with the use of a guinea 
pig anti-rat insulin antibody, 1251-labeled porcine insulin as 
tracer, and rat insulin as standard (Linco). Free and bound 
radioactivity were separated by use of an anti-IgG (goat 
anti-guinea pig) antibody (Linco). The sensitivity of the assay 
is 12 pmol/l, and the CV is ~7% at both low and high levels. 
Glucose was determined with the glucose oxidase method. 
MRI. After 10 mo on high-fat or control diet, six mice from 
each group underwent an MRI examination. All images were 
Table I. Recovery of leptin in mouse serum 
Concn, rig/ml 
Leptin, rig/ml Observed Expected Recovery, % 
0 0.4 0.4 100 
1 1.3 1.4 93 
2 2.2 2.4 92 
5 5.1 5.4 94 
Leptin at different concentrations was added to a mouse serum pool 
with a serum leptin concentration of 0.4 rig/ml. Serum was then 
determined for leptin concentrations and recovery was calculated. 
Table 2. Serum dilution of linearity of mouse 
leptin radioimmunoassay 
Volume Concentration, rig/ml Observed in % 
Sampled, of Expected 
Sample Pl Observed Expected Concentration 
A 100 10.5 10.5 100 
75 11.9 113 
50 13.1 125 
B 100 8.1 8.1 100 
75 8.7 108 
50 9.1 113 
C 100 4.6 4.6 100 
75 4.8 104 
50 5.1 110 
D 100 2.2 2.2 100 
75 2.4 107 
50 2.5 113 
Serums with known concentrations of leptin were diluted and 
leptin concentrations of the diluted serums were determined. 
obtained on an animal research MRI system with a magnetic 
field strength of 2.4 tesla (Bruker Biospec 24/30, Karlsruhe, 
Germany). Tl-weighted spin echo images were acquired in 
the axial plane with the following parameters: repetition 
time/echo time = 150/5 ms; matrix size, 192 X 128; field of 
view, 5 X 4 cm. Five contiguous slices of 3-mm thickness and a 
total imaging time of 4 min were performed in each animal. 
Before the imaging, the nonfasted animals were anesthetized 
with an intraperitoneal injection of a combination of mid- 
azolam (7.2 mg/kg; Hoffmann La Roche, Basel, Switzerland), 
fentanyl citrate (0.48 mg/kg; Janssen Pharmaceutics, Beerse, 
Belgium), and fluanisone (14.8 mg/kg; Janssen). In each 
animal, the areas of intra-abdominal and unilateral subcuta- 
neous fat content were measured with freehand regions of 
interest in one slice at the level of the urinary bladder and in a 
second slice 6 mm above the first one. Fat content was 
determined as area in square centimeters; total fat content 
was calculated as mean of the two measurements x 9 mm, 
i.e., as fat volume in cubic centimeters. 
Statistics. Means t SE are shown. Statistical analyses 
were performed with the SPSS for Windows system. Statisti- 
cal comparisons for the differences between mice on high-fat 
and control diet with regard to body weight and baseline 
plasma levels of leptin, insulin, and glucose were performed 
using Student’s unpaired t-test. Statistical comparisons be- 
fore and after the fasting were performed with Student’s 
paired t-test. Analysis of the normal distribution was per- 
formed with the Kolmogorov-Smirnov goodness-of-fit test. 
Pearson’s product-moment correlation was used to estimate 
linear relationships betwen variables. To describe relation- 
ships between two variables while adjusting for the effects of 
Table 3. Variation within and between assay 
for radioimmunoassay of leptin 
cv, % 
Mean, 
Sample rig/ml* Within assay Between assay 
1 0.4 2 0.1 11.2 14.6 
2 1.3 f 0.1 8.8 7.7 
3 2.2 + 0.1 4.0 5.9 
4 5.4 iI 0.2 4.9 3.3 
Values are means + SD. Repeated analysis for concentrations of 
leptin of 4 different mouse serum samples was performed for calcula- 
tion of within- and between-assay variation. CV, coefficient of varia- 
tion. *From 10 replicates. 
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a third variable, the partial correlation matrix of Pearson’s 
product-moment correlation was used. 
RESULTS 
Plasma leptin, insulin, and glucose. Plasma leptin 
increased with age in C57BLJ6J mice on the control diet 
and was 14.2 - + 1.6 nglml (n = 15) vs. 5.3 t 0.6 rig/ml at 
2 mo (n = 23, P < 0.001; Fig. 1). Consumption of a 
high-fat diet further increased plasma leptin, because 
after 10 mo, i.e., at 11 mo of age, plasma leptin had 
increased to 18.5 t_ 1.5 rig/ml in mice on high-fat diet 
(n = 18, P = 0.048 vs. controls; Fig. 1). The high-fat diet 
also increased plasma insulin and glucose levels, which 
was evident after 1 mo (P < O.OOl), whereas body 
weight was significantly different between the two 
groups of mice after 6 mo on high-fat diet (Fig. 1). 
Correlation with intra-abdominal and subcutaneous 
fat content. MRI was performed in mice after 10 mo of 
treatment with high-fat diet (n = 6) or control diet (n = 
6). MRI allowed us to visualize the intra-abdominal and 
subcutaneous fat and illustrated a large difference 
between the two groups (Fig. 2). Calculating the vol- 
ume of both intra-abdominal and subcutaneous fat 
revealed a marked elevation in the group given high-fat 
diet vs. the group given control diet. Thus intra- 
abdominal fat content at the level of determination was 
0.99 t 0.087 cm3 in controls vs. 2.55 t 0.17 cm3 in mice 
subjected to treatment with high-fat diet (P < O.OOl), 
and the corresponding figures for subcutaneous fat 
were 0.32 t 0.029 vs. 0.77 t 0.041 cm3 (P < 0.001). 
Furthermore, both the intra-abdominal (r = 0.92, P < 
0.001) and subcutaneous fat volume (r = 0.88, P < 
I 
3 6 9 12 
I I I 1 
0 3 6 9 12 
Months 
0.001) correlated significantly with log plasma leptin 
(Fig. 2). These correlation coefficients were similar to 
those between log plasma leptin and body weight (r = 
0.88, P < 0.001) and higher than those between plasma 
insulin and intra-abdominal fat content (r = 0.55, P = 
0.062), subcutaneous fat content (r = 0.62, P = 0.031), 
or body weight (r = 0.64, P = 0.024). 
Correlations between plasma leptin and insulin, glu- 
cose, body weight, and age. Plasma leptin levels across 
all animals at 2-11 mo of age (n = 160) correlated with 
body weight (r = 0.84, P < 0.001) as well as plasma 
insulin (r = 0.33, P < 0.001; Fig. 3). The plasma leptin 
levels did not, however, display a normal distribution 
(P = 0.0008 in the Kolmogorov-Smirnov goodness-of-fit 
test), and therefore, in the following correlations, the 
logarithmic value for plasma leptin was used. Log 
plasma leptin correlated significantly with body weight 
when calculated in both groups of mice at all ages (r = 
0.68, P < 0.001). Also plasma insulin (r = 0.23, P = 
0.003) and glucose (r = 0.17, P = 0.035) correlated with 
body weight, but to lower degrees. Log plasma leptin 
also correlated significantly with plasma insulin (r = 
0.38, P < 0.001) and with plasma glucose (r = 0.16, P = 
0.041). Partial correlation analysis revealed that log 
plasma leptin correlated with plasma insulin also after 
controlling for body weight, i.e., independently of body 
weight (r = 0.31, P < 0.001). We also calculated 
whether the increase in plasma leptin levels with age is 
due to the increased body weight by age. Partial 
correlation analysis between log plasma leptin levels 
and age in months after controlling for body weight was 
therefore performed. It was found that, after control for 
*** 
l- 
I I 
3 6 9 12 
I I I I 
3 6 9 12 
Months 
Fig. 1. Plasma levels of leptin, glucose, and insulin and 
body weight in C57BL/6J mice at various ages between 
2 and 11 mo. Mice were given normal (0) or high-fat (a) 
diet for 1, 2, 6, or 10 mo. Means -+ SE are shown. 
Probability level of random difference between groups: 
*P < 0.05, **‘p < 0.01, ***P < 0.001. There were 15-35 
animals in each group. 
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Fig. 2. A: representative magnetic resonance im- 
aging in C57BU6J mouse given high-fat (body 
weight, 35 g; plasma leptin, 26.7 rig/ml; left) and 
control (body weight, 26.2 g; plasma leptin, 8.1 
rig/ml; right) diet for 10 mo. Markedly increased 
content of intra-abdominal and subcutaneous fat 
seen in mouse given high-fat diet. B: correlation 
between volume of intra-abdominal or subcutane- 
ous fat and loe plasma leotin in C57BU6J mice 
given control (0: n = 6) or-high-fat (0, n = 6) diet 
for 10 mo. Fat content was determined in axial 
magnetic resonance images at level of urinary 
bladder and 6 mm above. 
. .o x 
c 
‘S 
3 15 d 0 
i!! 
r 
r=o.90 
% c 10 0 p<o.oo 1 
8 ’ 
0 1 2 3 4 
Intraabdominal 
Fat Volume (cm3) 
0 2 4 6 8 10 
Subcutaneous 
Fat Volume (cm3x 10) 
body weight, log plasma correlated significantly with 
age in control mice 0” = 0.25, P = 0.031) but not in mice 
given the high-fat diet (P = 0.69). 
Plasma leptin after 48-h fasting. After 2 mo of 
treatment with high-fat diet or control diet, mice 
underwent a 48-h fasting period. Figure 4 shows that 
plasma levels of leptin, insulin, and glucose as well as 
body weight decreased significantly during fasting in 
both groups. Comparing the percent reduction from 
values before fasting revealed that mice on control diet 
had a more marked reduction in plasma leptin (-44 + 
3%) than those on high-fat diet (-16 + 7%, P = 0.001). 
Similarly, the reduction in body weight was higher in 
control mice (- 3.2 t 0.1 g) than in high-fat diet-treated 
mice (-2.8 g It 0.1 g, P = 0.0021, whereas the reduction 
in plasma insulin was the same in the two groups of 
mice [-lo2 t 20 pmol/l in control mice vs. -104 + 35 
pmol/l in high-fat diet-treated mice, nonsignificant 
(NS)]. Thus the difference in plasma insulin between 
the two groups of mice persisted unaltered throughout 
the fasting period. In contrast, the reduction in plasma 
glucose was more pronounced in high-fat diet-treated 
mice (-2.9 + 0.2 mmolA) than in control mice (-2.0 + 
0.3 mmol/l, P = 0.020). Correlation analysis revealed 
that the reduction in plasma leptin during fasting 
correlated with the reduction in plasma insulin (r = 
0.43, P = 0.012; Fig. 5). In contrast, the reduction in 
leptin during fasting did not correlate with prefasting 
body weight 0” = 0.12, NS) or with the change in body 
weight during fasting (r = 0.23, NS). 
DISCUSSION 
In this study, we have developed a new radioimmuno- 
assay for measuring plasma leptin in mice, thus allow- 
ing investigation of factors involved in the regulation of 
plasma leptin in rodents. The radioimmunoassay was 
found to be specific, exhibiting a high recovery (>90%) 
and low intra- and interassay variability. With this new 
radioimmunoassay, we examined the regulation of 
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Fig. 5. Correlation of changes in plasma insulin and changes in 
plasma leptin during a 48-h fast in 3 mo-old C57BL/6J mice treated 
with a high-fat (0, n = 18) or control (0, n = 15) diet for 2 mo. 
Regression line and P and r values for correlation are also shown. 
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Fig. 3. Correlation of plasma leptin and body weight and plasma 
leptin and plasma insulin in C57BLkJ mice of 2,3,7, or 11 mo of age 
given control (0, n = 73) or high-fat (0, n = 87) diet for 1,2,6, or 10 
mo (total n = 160). Regression line and P and r values for correlation 
plasma leptin under conditions when plasma insulin is 
increased (during insulin resistance) and reduced (dur- 
ing fasting) in C57BU6J mice. We demonstrate that 
plasma leptin increases with age in the mice and that 
challenging the animals with a high-fat diet further 
augments this increase in plasma leptin. These results 
are in agreement with those of previous studies show- 
ing increased ob gene expression in adipocytes of 
are also shown. C57BL/6J mice after high-f& diet for 14 or 16 wk (6,23) 
Sgh-fat diet 
L 
25 
1 Control diet High-fat diet Intro1 diet 
1111 Fig. 4. Plasma levels of leptin, glucose, and 
Control diet 
insulin and body weight in Cc7BL/6> mice at age 
3 mo given a control (n = 15) or high-fat (n = 18) 
diet for 2 mo, before (open bars) and after (filled 
High-fat diet bars) 48-h fasting. Means 5 SE are shown. *P < 
T 
*.05;***p < 0.001. High-fat diet -r 
-L 
250 1 a 7 1 Control diet 
- 
* 
*** 
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and increased circulating leptin as determined by 
quantitative Western blot analysis in FVB mice after 
12 wk on high-fat diet (10). We also found a correlation 
between plasma leptin and body weight in accordance 
with previous reports (10, 22). The age-dependent 
increase in leptin levels appears to be largely depen- 
dent on the increased body weight, although we also 
found an independent influence of age on plasma 
leptin. Hence this study shows that body weight, age, 
and fat content of the diet all affect plasma leptin 
concentrations in mice. In this study, we also assessed 
the body fat content using MRI, which is a sensitive 
technique for distinguishing fat from surrounding tis- 
sue (1). We found that both intra-abdominal and subcu- 
taneous fat content increased in mice on the high-fat 
diet and that plasma leptin correlated to a high degree 
(r > 0.9) with fat content. These data suggest that 
leptin is synthesized and secreted from the fat cell in 
relation to body fat content. 
Challenging C57BL/6J mice with a high-fat diet has 
previously been shown to induce insulin resistance 
(29). This is apparent in the present study, because 
hyperinsulinemia was observed after 1 mo of treatment 
with high-fat diet. We found that plasma leptin corre- 
lates with plasma insulin in mice (r = 0.38). A previous 
study showed that ob gene expression correlates with 
plasma insulin in C57BL/6J mice (24), and we have 
recently found correlations between plasma leptin and 
circulating insulin in humans (16,19). This correlation 
between circulating levels of insulin and leptin might 
be secondary to a stimulatory influence of insulin on ob 
gene expression. However, possible influences of leptin 
on insulin secretion, as inferred from a recent demon- 
stration of leptin receptors on the insulin-producing 
p-cells (17), cannot be excluded. 
Although not previously demonstrated, our finding of 
a significant correlation between plasma leptin and 
plasma insulin in mice might be regarded as expected, 
because body weight correlates with both plasma leptin 
and plasma insulin. To examine whether the correla- 
tion between plasma leptin and plasma insulin is 
simply due to both parameters correlating with body 
weight, we performed a partial correlation analysis 
between plasma leptin and plasma insulin, controlling 
for the influence of body weight. This analysis revealed 
that plasma leptin and plasma insulin were correlated 
independently of body weight. Therefore, the present 
study suggests that leptin and insulin are either re- 
lated to each other through a mutual action or a third 
factor is involved in the regulation of plasma leptin and 
plasma insulin. One explanation could be that insulin 
stimulates the synthesis and secretion of leptin, be- 
cause increased fat content is associated with insulin 
resistance and hyperinsulinemia. Such a hypothesis is 
supported by several reports that insulin stimulates ob 
gene expresion in adipocytes (8, 18, 24, 27) and that 
supraphysiological insulin infusions increase plasma 
leptin in humans within 4-6 h (15, 30). Alternatively, 
the increased plasma leptin levels may be related to the 
insulin resistance and therefore have evolved indepen- 
dently of hyperinsulinemia. 
Fasting was found to reduce pla sma leptin levels 
coincidentally with the reduced body weight and lower- 
ing of insulin and glucose. Previous studies have shown 
that fasting reduces the ob gene expression in both rats 
and mice (3, 11, 21,24,28), and it has also been shown 
that fasting reduces circulating leptin in mice (2, 11) 
and rats (13). Leptin might therefore be a hormonal 
signal of nutritional status, both in obesity, when 
plasma leptin is increased, and in fasting, when plasma 
leptin is reduced. In fasting, the reduction in plasma 
leptin may contribute to the increased drive for food 
intake. Interestingly, we found that the reduction in 
plasma leptin during fasting was impaired in mice 
made obese and insulin-resistant on a high-fat diet 
despite these animals having an exaggerated reduction 
of plasma glucose. One mechanism underlying this 
insensitivity would be the insulin resistance in these 
mice, if it is the reduced insulin level that contributes to 
the lowered leptin secretion during fasting. This is a 
possible explanation, because we found that the reduc- 
tion in plasma leptin during fasting correlated with the 
reduction in circulating insulin levels and not with - 
prefasting body weight or with changes in body weight. 
It was previously shown that administering leptin to 
fasted mice prevented the starvation-induced effects on 
the gonadal, adrenal, and thyroid axes without influenc- 
ing the lowered insulin and glucose levels (2). This was 
suggested to indicate that insulin and leptin may 
cooperate to regulate the neuroendocrine responses to 
starvation. Our present results also suggest that insu- 
lin seems to be involved in the regulation of circulating 
leptin during starvation in mice. 
In summary, the results of this study show that 
plasma leptin is increased with age and after a high-fat 
diet in C57BL/6J mice and that plasma leptin concen- 
trations correlate with body weight and with intra- 
abdominal and subcutaneous fat content. In addition, 
plasma leptin correlates with plasma insulin indepen- 
dently of body weight. Furthermore, 48-h fasting re- 
duces plasma leptin in conjunction with reduced body 
weight and plasma insulin. The fasting-induced reduc- 
tion in plasma’leptin is inhibited by high-fat diet and 
correlates with’ the reduction in plasma insulin. We 
conclude that plasma leptin concentrations in mice are 
increased with age and affected by nutritional status 
and that plasma leptin is related to plasma insulin 
independently of adiposity. 
Perspectives 
Leptin, a protein produced in and released from 
adipocytes, was recently discovered by positional clon- 
ing of the ob gene in obese diabetic mice. Acting via 
cytokine-like receptors in the central nervous system, 
leptin reduces food intake and body weight in mice. 
Leptin therefore appears to be a hormonal signal in a 
feedback system controlling body weight. Thus factors 
regulating food intake and body weight might operate 
through changes in circulating leptin. It is therefore 
important to characterize the regulation of circulating 
leptin. Most importantly, circulating leptin is con- 
trolled by the body fat content. However, adiposity 
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explains only -50% of the variations in plasma leptin, 
suggesting th .at other factors are involved in the physi- 
ological regulation of circulating leptin 
ies have demonstrate d that circulating 
Previ 
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higher 
in women than in men, undergoes a diurnal variation, 
and appears to be related to insulin secretion. With a 
newly developed radioimmunoassay for murine leptin, 
we found that a high-fat diet increases and fasting 
reduces circulating leptin in mice. These results sup- 
port the hypothesis that leptin is a hormonal signal of 
nutritional status, both in obesity, when circulating 
leptin is increased, and in fasting, when circulating 
leptin is reduced. The demonstration in the present 
study that leptin correlates with circulating insulin 
independently of body weight indicates that insulin is 
involved in the regulation of circulating leptin in mice. 
Further studies are now needed to examine the mecha- 
nisms regulating leptin secretion and the physiological 
implications of the relationship between insulin and 
leptin. 
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